August 15, 2014 | As greater numbers of women seek out genetic tests to predict their lifetime risks of developing breast cancer, more borderline cases are surfacing, where risks are elevated but not overwhelming. In the case of mutations to genes like PALB2, which may confer a roughly one in three chance of developing cancer, patients must make difficult personal decisions about preventive measures. Boston Globe